Results 1 to 10 of about 7,921 (151)
Some of the next articles are maybe not open access.

Investigation of varenicline and tropisetron in latent inhibition and novel object recognition in mice [PDF]

open access: yesScientific Reports
There is currently no treatment for cognitive-impairment associated with schizophrenia (CIAS). Animal and human studies suggest that nicotinic cholinergic agonists and 5-HT3 antagonists have potential therapeutic benefits.
Lorena R. Lizarraga-Valderrama   +5 more
doaj   +2 more sources

Electronic Cigarettes Versus Varenicline for Smoking Cessation: A Systematic Review and Meta-analysis of in-person Support Augmentation Strategies [PDF]

open access: yesIndian Journal of Community Medicine
Tobacco smoking is a global health crisis, causing over 8 million deaths annually, including 1.3 million in India. The rise of electronic cigarettes (e-cigarettes) has raised questions about their effectiveness compared to traditional aids like ...
Aruhi Sinha   +2 more
doaj   +2 more sources

Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC) [PDF]

open access: yesJournal of Health Economics and Outcomes Research
# Background Pharmacologic options for supporting smoking cessation remain limited. Cytisinicline is a plant-based alkaloid that selectively binds to α4β2 nicotinic acetylcholine receptors, reducing nicotine craving and withdrawal symptoms, and has ...
Mark Rubinstein   +3 more
doaj   +2 more sources

Utilization of varenicline among Kansas Medicaid enrollees. [PDF]

open access: yesPLoS ONE
BackgroundSmoking prevalence among Medicaid beneficiaries is twice that of privately insured adults, yet effective smoking cessation treatments remain underutilized.
Nathalia M Machado   +3 more
doaj   +2 more sources

Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease

open access: yesBrazilian Journal of Medical and Biological Research, 2021
The beneficial effects of drugs that act via nicotinic acetylcholine receptors (nAChRs) on Parkinson's disease (PD) symptomatology may explain the negative correlation between cigarette smoking and risk of this neurological condition.
A. Ribeiro-Carvalho   +6 more
doaj   +1 more source

The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage

open access: yesBiomedicines, 2023
Dengue virus (DENV) poses a significant global health challenge, with millions of cases each year. Developing effective antiviral drugs against DENV remains a major hurdle. Varenicline is a medication used to aid smoking cessation, with anti-inflammatory
Ching-Lin Lin   +10 more
doaj   +1 more source

Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression

open access: yesJournal of Pharmacological Sciences, 2020
Varenicline is a widely used and effective drug for smoking cessation. We previously reported that varenicline aggravates atherosclerosis in apolipoprotein E knockout (ApoE KO) mice.
Mitsuhisa Koga   +7 more
doaj   +1 more source

Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials

open access: yesIndian Journal of Psychiatry, 2023
According to the Global Burden of Disease (GBD) Study conducted in 2019, smoking tobacco leads to over 8 million deaths each year. Hence, it is crucial to identify optimal smoking cessation therapy. To compare the efficacy of varenicline versus bupropion
Ashish R. Patel   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy